Role of interleukin-32 in cancer progression (Review)

Interleukin (IL)-32 is induced by pro-inflammatory cytokines and promotes the release of inflammatory cytokines. Therefore, it can promote inflammatory responses. The present review article summarized the role of the receptors required for IL-32 action, the biological function of IL-32 and its mecha...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters 2024-02, Vol.27 (2), p.1
Main Authors: Meng, Danyang, Dong, Hang, Wang, Chennan, Zang, Rongjia, Wang, Jianjie
Format: Article
Language:English
Subjects:
Cancer
Colorectal cancer
Development and progression
Interleukins
Lung cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page 1
container_title Oncology letters
container_volume 27
creator Meng, Danyang
Dong, Hang
Wang, Chennan
Zang, Rongjia
Wang, Jianjie
description Interleukin (IL)-32 is induced by pro-inflammatory cytokines and promotes the release of inflammatory cytokines. Therefore, it can promote inflammatory responses. The present review article summarized the role of the receptors required for IL-32 action, the biological function of IL-32 and its mechanism of action in tumors. Moreover, it assessed the significance of aberrant IL-32 expression in associated diseases and analyzed the effects of IL-32 on four key types of cancer: Colorectal, gastric, breast and lung. However, the mechanism of action of IL-32 needs to be further demonstrated by assessing the role of this cytokine in cancer to elucidate novel and reliable targets for future cancer treatments. Key words: interleukin-32, colorectal cancer, gastric cancer, breast cancer, lung cancer
doi_str_mv 10.3892/01.2023.14187
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A782322197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A782322197</galeid><sourcerecordid>A782322197</sourcerecordid><originalsourceid>FETCH-LOGICAL-g987-5e778da68de46bd2863368451af67ee3b5897290d297f169914975c542851a573</originalsourceid><addsrcrecordid>eNptj81LAzEQxXNQsNQevS8Ioodd8_1xLEWrUBBK7yXdnWyjaSKbrf77RvRQwTeH4Q2_N_AQuiK4YdrQe0waiilrCCdanaEJUYbWBCt-gWY5v-IiIYnWcoLEOgWokqt8HGEIcHzzsWa02Kq1sYWheh9SP0DOPsXqdg0fHj7vLtG5syHD7HdP0ebxYbN4qlcvy-fFfFX3RqtagFK6s1J3wOWuo1oyJjUXxDqpANhOaKOowR01yhFpDOFGiVZwqgsjFJui65-3vQ2w9dGlcbDtwed2O1eaMkqJ-aaaf6gyHRx8myI4X-5_AjcngT3YMO5zCsexVMyn4BdyTF7o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Role of interleukin-32 in cancer progression (Review)</title><source>PubMed Central</source><creator>Meng, Danyang ; Dong, Hang ; Wang, Chennan ; Zang, Rongjia ; Wang, Jianjie</creator><creatorcontrib>Meng, Danyang ; Dong, Hang ; Wang, Chennan ; Zang, Rongjia ; Wang, Jianjie</creatorcontrib><description>Interleukin (IL)-32 is induced by pro-inflammatory cytokines and promotes the release of inflammatory cytokines. Therefore, it can promote inflammatory responses. The present review article summarized the role of the receptors required for IL-32 action, the biological function of IL-32 and its mechanism of action in tumors. Moreover, it assessed the significance of aberrant IL-32 expression in associated diseases and analyzed the effects of IL-32 on four key types of cancer: Colorectal, gastric, breast and lung. However, the mechanism of action of IL-32 needs to be further demonstrated by assessing the role of this cytokine in cancer to elucidate novel and reliable targets for future cancer treatments. Key words: interleukin-32, colorectal cancer, gastric cancer, breast cancer, lung cancer</description><identifier>ISSN: 1792-1074</identifier><identifier>DOI: 10.3892/01.2023.14187</identifier><language>eng</language><publisher>Spandidos Publications</publisher><subject>Cancer ; Colorectal cancer ; Development and progression ; Interleukins ; Lung cancer</subject><ispartof>Oncology letters, 2024-02, Vol.27 (2), p.1</ispartof><rights>COPYRIGHT 2024 Spandidos Publications</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Meng, Danyang</creatorcontrib><creatorcontrib>Dong, Hang</creatorcontrib><creatorcontrib>Wang, Chennan</creatorcontrib><creatorcontrib>Zang, Rongjia</creatorcontrib><creatorcontrib>Wang, Jianjie</creatorcontrib><title>Role of interleukin-32 in cancer progression (Review)</title><title>Oncology letters</title><description>Interleukin (IL)-32 is induced by pro-inflammatory cytokines and promotes the release of inflammatory cytokines. Therefore, it can promote inflammatory responses. The present review article summarized the role of the receptors required for IL-32 action, the biological function of IL-32 and its mechanism of action in tumors. Moreover, it assessed the significance of aberrant IL-32 expression in associated diseases and analyzed the effects of IL-32 on four key types of cancer: Colorectal, gastric, breast and lung. However, the mechanism of action of IL-32 needs to be further demonstrated by assessing the role of this cytokine in cancer to elucidate novel and reliable targets for future cancer treatments. Key words: interleukin-32, colorectal cancer, gastric cancer, breast cancer, lung cancer</description><subject>Cancer</subject><subject>Colorectal cancer</subject><subject>Development and progression</subject><subject>Interleukins</subject><subject>Lung cancer</subject><issn>1792-1074</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptj81LAzEQxXNQsNQevS8Ioodd8_1xLEWrUBBK7yXdnWyjaSKbrf77RvRQwTeH4Q2_N_AQuiK4YdrQe0waiilrCCdanaEJUYbWBCt-gWY5v-IiIYnWcoLEOgWokqt8HGEIcHzzsWa02Kq1sYWheh9SP0DOPsXqdg0fHj7vLtG5syHD7HdP0ebxYbN4qlcvy-fFfFX3RqtagFK6s1J3wOWuo1oyJjUXxDqpANhOaKOowR01yhFpDOFGiVZwqgsjFJui65-3vQ2w9dGlcbDtwed2O1eaMkqJ-aaaf6gyHRx8myI4X-5_AjcngT3YMO5zCsexVMyn4BdyTF7o</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Meng, Danyang</creator><creator>Dong, Hang</creator><creator>Wang, Chennan</creator><creator>Zang, Rongjia</creator><creator>Wang, Jianjie</creator><general>Spandidos Publications</general><scope/></search><sort><creationdate>20240201</creationdate><title>Role of interleukin-32 in cancer progression (Review)</title><author>Meng, Danyang ; Dong, Hang ; Wang, Chennan ; Zang, Rongjia ; Wang, Jianjie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g987-5e778da68de46bd2863368451af67ee3b5897290d297f169914975c542851a573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cancer</topic><topic>Colorectal cancer</topic><topic>Development and progression</topic><topic>Interleukins</topic><topic>Lung cancer</topic><toplevel>online_resources</toplevel><creatorcontrib>Meng, Danyang</creatorcontrib><creatorcontrib>Dong, Hang</creatorcontrib><creatorcontrib>Wang, Chennan</creatorcontrib><creatorcontrib>Zang, Rongjia</creatorcontrib><creatorcontrib>Wang, Jianjie</creatorcontrib><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meng, Danyang</au><au>Dong, Hang</au><au>Wang, Chennan</au><au>Zang, Rongjia</au><au>Wang, Jianjie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of interleukin-32 in cancer progression (Review)</atitle><jtitle>Oncology letters</jtitle><date>2024-02-01</date><risdate>2024</risdate><volume>27</volume><issue>2</issue><spage>1</spage><pages>1-</pages><issn>1792-1074</issn><abstract>Interleukin (IL)-32 is induced by pro-inflammatory cytokines and promotes the release of inflammatory cytokines. Therefore, it can promote inflammatory responses. The present review article summarized the role of the receptors required for IL-32 action, the biological function of IL-32 and its mechanism of action in tumors. Moreover, it assessed the significance of aberrant IL-32 expression in associated diseases and analyzed the effects of IL-32 on four key types of cancer: Colorectal, gastric, breast and lung. However, the mechanism of action of IL-32 needs to be further demonstrated by assessing the role of this cytokine in cancer to elucidate novel and reliable targets for future cancer treatments. Key words: interleukin-32, colorectal cancer, gastric cancer, breast cancer, lung cancer</abstract><pub>Spandidos Publications</pub><doi>10.3892/01.2023.14187</doi></addata></record>
fulltext fulltext
identifier ISSN: 1792-1074
ispartof Oncology letters, 2024-02, Vol.27 (2), p.1
issn 1792-1074
language eng
recordid cdi_gale_infotracmisc_A782322197
source PubMed Central
subjects Cancer
Colorectal cancer
Development and progression
Interleukins
Lung cancer
title Role of interleukin-32 in cancer progression (Review)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A11%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20interleukin-32%20in%20cancer%20progression%20(Review)&rft.jtitle=Oncology%20letters&rft.au=Meng,%20Danyang&rft.date=2024-02-01&rft.volume=27&rft.issue=2&rft.spage=1&rft.pages=1-&rft.issn=1792-1074&rft_id=info:doi/10.3892/01.2023.14187&rft_dat=%3Cgale%3EA782322197%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g987-5e778da68de46bd2863368451af67ee3b5897290d297f169914975c542851a573%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A782322197&rfr_iscdi=true